IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ)
$4.1 -0.2 (-4.6512%)
Analysed IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) News Sources
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
11-05-2026
yahoo.com
Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
11-05-2026
yahoo.com
Iovance (IOVA): The Best Penny Stock to Buy Before It Explodes
13-05-2026
yahoo.com
Iovance Biotherapeutics to Present at Upcoming Conference
21-05-2026
yahoo.com
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
22-05-2026
yahoo.com
Assessing Iovance Biotherapeutics (IOVA) Valuation After Strong Recent Share Price Momentum
23-05-2026
yahoo.com
Soft Tissue Sarcoma with Lung Metastases Market Set to Expand Across the 7MM During the Forecast Period (2026-2036) with Advancing Targeted and Cellular Therapies | DelveInsight
26-05-2026
yahoo.com
AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?
28-05-2026
yahoo.com
ImmunityBio: Anktiva Explained and What Comes Next
29-05-2026
yahoo.com
IBRX Stock Outlook After Q1 Results and a New FDA Review
29-05-2026
yahoo.com
What is the current price of IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ)?
The current price of IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) is $4.1.
IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) absolute price change since previous trading day?
The absolute price change of IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) since the previous trading day is $-0.2.
IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) percentage price change since previous trading day?
The percentage price change of IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) since the previous trading day is -4.6512%.
What is the most recent average sentiment score for IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ)?
The most recent average sentiment score for IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ)?
The most recent sentiment for IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ) is .
SEC-8K** Filing Available For IOVANCE BIOTHERAPEUTICS INC (IOVA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.